Series A - Labviva

Series A - Labviva

Investment Firm

Overview

Labviva is a digital marketplace for life science products that connects researchers with suppliers.

Announced Date

Mar 27, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Biospring Partners

Biospring Partners

Biospring Partners is a late_stage_venture and private_equity firm.

Participant Investors

4

Investor Name
Participant InvestorSenator Investment Group
Participant InvestorBiospring Partners
Participant InvestorGlasswing Ventures
Participant InvestorB Capital

Round Details and Background

Labviva raised $20000000 on 2023-03-27 in Series A

Labviva is a digital marketplace for life science products that connects researchers with suppliers.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 22, 2019
Seed Round - Labviva
4-2.0M
May 31, 2020
Venture Round - Labviva
3-undefined
Jun 21, 2021
Seed Round - Labviva
4-8.0M
Mar 27, 2023
Series A - Labviva
4-20.0M

Recent Activity

There is no recent news or activity for this profile.